What is Myomo Inc (MYO) stock price today?

Myomo Inc (MYO) currently trades at $0.86 per share. The stock has a market capitalization of $32.00M and a P/E ratio of —x.

Is MYO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Myomo Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Myomo Inc's revenue and earnings?

Myomo Inc has trailing twelve-month (TTM) revenue of $40.93M with profit margins of -38.10%. Earnings per share (EPS) is $-0.37.

Is MYO stock overvalued or undervalued?

Based on our DCF model, Myomo Inc's intrinsic value is $4.56, representing a margin of safety of 82.40%. The stock currently trades at a P/E of —x.

MYO

Myomo Inc

NYSE MKT: MYO · HEALTHCARE · MEDICAL DEVICES

$0.86

+8.54% today

Updated 2026-04-30

Market cap

$32.00M

P/E ratio

—

P/S ratio

0.78x

EPS (TTM)

$-0.37

Dividend yield

—

52W range

$1 – $5

Volume

0.4M

Market cap

$32.00M

P/E ratio

—

P/S ratio

0.78x

EPS (TTM)

$-0.37

Dividend yield

—

52W range

$1 – $5

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$4.32

+402.56%

12-Month target

—

Intrinsic (DCF)

$4.56

Margin of safety

+82.40%

Price chart

X-Ray snapshot

Strengths

+ 82.40% below intrinsic value

Risks

- Thin margins at -38.10%

- Negative free cash flow $-1.81M

- Revenue declining -5.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$15.56M	$19.24M	$32.55M	$40.93M	$40.93M
Net income	$-10.72M	$-8.15M	$-6.18M	$-15.57M	$-3.81M
EPS	—	—	—	—	$-0.37
Free cash flow	$-10.35M	$-6.32M	$-4.65M	$-16.25M	$-1.81M
Profit margin	-68.92%	-42.34%	-19.00%	-38.05%	-38.10%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MYO	$32.00M	30	5.3	2.0	6.7	5.0	+82.40%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Myomo Inc trades at $0.86. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $40.93M. with profit margins at -38.10%. Our DCF model estimates intrinsic value at $4.56.

Frequently asked questions

What is Myomo Inc's stock price?

Myomo Inc (MYO) trades at $0.86.

Is Myomo Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $4.56.

What is the price target of Myomo Inc (MYO)?

The analyst target price is $4.32, representing +402.6% upside from the current price of $0.86.

What is the intrinsic value of Myomo Inc (MYO)?

Based on our DCF model, intrinsic value is $4.56, a +82.4% margin of safety versus $0.86.

What is Myomo Inc's revenue?

TTM revenue is $40.93M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNYSE MKT

CurrencyUSD

Quick metrics

P/S ratio0.78x

ROE-86.20%

Beta1.16

50D MA$0.75

200D MA$1.02

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MYO vs LLY →MYO vs JNJ →MYO vs ABBV →Stock screener →